41P The SARS-CoV-2 vaccine and enrollment of patients with cancer in phase I trials: The experience at Institute Gustave Roussy

Detalles Bibliográficos
Autores principales: Belcaid, L., Baldini, C., Laparra, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society for Medical Oncology. Published by Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902373/
http://dx.doi.org/10.1016/j.annonc.2022.01.050
_version_ 1784664584515223552
author Belcaid, L.
Baldini, C.
Laparra, A.
author_facet Belcaid, L.
Baldini, C.
Laparra, A.
author_sort Belcaid, L.
collection PubMed
description
format Online
Article
Text
id pubmed-8902373
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher European Society for Medical Oncology. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-89023732022-03-08 41P The SARS-CoV-2 vaccine and enrollment of patients with cancer in phase I trials: The experience at Institute Gustave Roussy Belcaid, L. Baldini, C. Laparra, A. Ann Oncol Article European Society for Medical Oncology. Published by Elsevier Ltd. 2022-03 2022-03-08 /pmc/articles/PMC8902373/ http://dx.doi.org/10.1016/j.annonc.2022.01.050 Text en Copyright © 2022 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Belcaid, L.
Baldini, C.
Laparra, A.
41P The SARS-CoV-2 vaccine and enrollment of patients with cancer in phase I trials: The experience at Institute Gustave Roussy
title 41P The SARS-CoV-2 vaccine and enrollment of patients with cancer in phase I trials: The experience at Institute Gustave Roussy
title_full 41P The SARS-CoV-2 vaccine and enrollment of patients with cancer in phase I trials: The experience at Institute Gustave Roussy
title_fullStr 41P The SARS-CoV-2 vaccine and enrollment of patients with cancer in phase I trials: The experience at Institute Gustave Roussy
title_full_unstemmed 41P The SARS-CoV-2 vaccine and enrollment of patients with cancer in phase I trials: The experience at Institute Gustave Roussy
title_short 41P The SARS-CoV-2 vaccine and enrollment of patients with cancer in phase I trials: The experience at Institute Gustave Roussy
title_sort 41p the sars-cov-2 vaccine and enrollment of patients with cancer in phase i trials: the experience at institute gustave roussy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902373/
http://dx.doi.org/10.1016/j.annonc.2022.01.050
work_keys_str_mv AT belcaidl 41pthesarscov2vaccineandenrollmentofpatientswithcancerinphaseitrialstheexperienceatinstitutegustaveroussy
AT baldinic 41pthesarscov2vaccineandenrollmentofpatientswithcancerinphaseitrialstheexperienceatinstitutegustaveroussy
AT laparraa 41pthesarscov2vaccineandenrollmentofpatientswithcancerinphaseitrialstheexperienceatinstitutegustaveroussy

Ejemplares similares